B. Braun receives FDA clearance for SpaceStation MRI

August 31, 2020 – B. Braun Medical Inc. (Bethlehem, PA) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the SpaceStation MRI to allow Space® infusion pumps to continuously deliver medications to patients within the MRI suite.

The SpaceStation MRI is designed to shield Space infusion pumps against 1.5-T and 3.0-T magnetic fields to protect the MR scanner and provide interference-free images. Long infusion lines are no longer needed and hospital-wide Space infusion pumps are now able to safely transition patients into the imaging suite with the SpaceStation MRI, the company says.

Key features of the SpaceStation MRI include:

  • Each station holds up to four Space pumps – Including the Infusomat Space Large Volume Pump, Perfusor Space Syringe Pump, and the Perfusor PCA Syringe Pump.
  • Integrated TeslaSpy – Continuously monitors magnetic field strength to provide proper placement and positioning of the SpaceStation MRI.
  • Pump status window – Allows for visibility of all infusion pumps with a centralized alarm display to continuously monitor the status on all infusions during imaging.
  • Standard Space infusion lines – Can be used with the Infusomat Space Large Volume Infusion Pump and non-dedicated disposables are available for the Perfusor Space Syringe Infusion Pump.
  • Full drug library software available with DoseGuard (Dose Error Reduction Software) Drug Library Development Software, powered by FDB Infusion Knowledge – Allows online collaboration, access to FDB reference materials, and customizable drug hard and soft limits.

“This clearance allows us to expand our infusion therapy portfolio by providing seamless infusion management across multiple care settings,” said Jonathan Stapley, director of marketing for Infusion Systems at B. Braun Medical. “Our Space Infusion System allows standardization of large volume and syringe pumps on the same workflow with one integration.”

Learn More